von Kroge, Philipp H.
Duprée, Anna
Mann, Oliver
Izbicki, Jakob R.
Wagner, Jonas
Ahmadi, Paymon
Weidemann, Sören
Adjallé, Raissa
Kröger, Nicolaus
Bokemeyer, Carsten
Fiedler, Walter
Modemann, Franziska
Ghandili, Susanne
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 5 July 2022
Accepted: 27 January 2023
First Online: 6 February 2023
Declarations
:
: The data collection was performed in accordance with local legal requirements and was reviewed and approved by the ethics committee of the Medical Council of Hamburg (Nr. 2022-300144-WF). Informed consent was waived by the ethics committee since only anonymous data were analyzed and published.
: Not applicable.
: F.M. received support for meeting attendance from Servier, AbbVie, Incyte, Gilead, Jazz Pharmaceuticals, Novartis, Teva, Pfizer, and Amgen; received research grants from Apis Technologies, Daiichi Sankyo; and received speaker honoraria from Servier, Jazz Pharmaceuticals, and AbbVie. C.B. received speaker honoraria from AOK Germany, Bristol Myers Squipp, med update, Merck Serono, Roche Pharma, Sanofi Aventis and participated on advisory boards for Astra Zeneca, Bayer Healthcare, Berlin Chemie, Bristol Myers Squipp, GSO Research Organisation, Jansen Cilag, Merck Serono, Merck Sharp Dohme, Novartis, and Sanofi Aventis. W.F. participated in advisory boards for Morphosys, AbbVie, Pfizer, Amgen, Jazz Pharmaceuticals, and Clinigen, received support for meeting attendance from Amgen, Jazz Pharmaceuticals, Daiichi Sankyo Oncology, Bristol Myers Squibb, and Servier, and received support for medical writing from Amgen, Boehringer Ingelheim, Pfizer, and AbbVie. For the remaining authors, none were declared.